A Mab A Case Study In Bioprocess Development Jun 2026

The outcome was a robust run, where the culture achieved a final titer of 4.5 g/L —a benchmark that makes the manufacturing economically viable.

Initial serum-free media yielded only 1.5 g/L of A Mab. The bioprocess team performed a screening 24 components. The breakthrough came with: A Mab A Case Study In Bioprocess Development